Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats

Toxicological Sciences

Volumn 122, Issue 1, 2011, Pages 112-120

  Carr, Russell L ^a   Borazjani, Abdolsamad ^a   Ross, Matthew K ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Chlorpyrifos; Developmental neurotoxicology; Endocannabinoid

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CHLORPYRIFOS; CHOLINESTERASE; ENDOCANNABINOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN DEVELOPMENT; BRAIN LEVEL; BRAIN MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FOREBRAIN; HYDROLYSIS; JUVENILE ANIMAL; MALE; NEUROTOXICITY; NONHUMAN; RAT; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 79960976535     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr081     Document Type: Article

References (83)

1. Aldridge, J. E., Levin, E. D., Seidler, F. J., and Slotkin, T. A. (2005a). Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 113, 527-531.
2. Aldridge, J. E., Meyer, A., Seidler, F. J., and Slotkin, T. A. (2005b). Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 113, 1027-1031.
3. Aldridge, J. E., Meyer, A., Seidler, F. J., and Slotkin, T. A. (2005c). Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Toxicol. Appl. Pharmacol. 203, 132-144.
4. Aldridge, J. E., Seidler, F. J., Meyer, A., Thillai, I., and Slotkin, T. A. (2003). Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ. Health Perspect. 111, 1736-1743.
5. Aldridge, J. E., Seidler, F. J., and Slotkin, T. A. (2004). Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 112, 148-155.
6. Anavi-Goffer, S., and Mulder, J. (2009). The polarised life of the endocannabinoid system in CNS development. Chembiochem 10, 1591-1598.
7. Auman, J. T., Seidler, F. J., and Slotkin, T. A. (2000). Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. Dev. Brain Res. 121, 19-27.
8. Bermudez-Silva, F. J., Viveros, M. P., McPartland, J. M., and Rodriguez de Fonseca, F. (2010). The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol. Biochem. Behav. 95, 375-382.
9. Betancourt, A. M., Filipov, N. M., and Carr, R. L. (2007). Alteration of neurotrophins in the hippocampus and cerebral cortex of young rats exposed to chlorpyrifos and methyl parathion. Toxicol. Sci. 100, 445-455.
10. Blankman, J. L., Simon, G. M., and Cravatt, B. F. (2007). A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347-1356.
11. Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2007). Antidepressantlike activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol. Psychiatry 62, 1103-1110.
12. Campolongo, P., Trezza, V., Ratano, P., Palmery, M., and Cuomo, V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology Forthcoming.
13. Effect of different administration paradigms on cholinesterase inhibition following repeated chlorpyrifos exposure in late preweanling rats
14. Casey, B. J., Getz, S., and Galvan, A. (2008). The adolescent brain. Dev. Rev. 28, 62-77.
15. Chambers, J. E., Wiygul, S. M., Harkness, J. E., and Chambers, H. W. (1988). Effects of acute paraoxon and atropine exposures on retention of shuttle avoidance behavior in rats. Neurosci. Res. Commun. 3, 85-92.
16. Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., and Gessa, G. L. (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63, L113-L117.
17. Dam, K., Garcia, S. J., Seidler, F. J., and Slotkin, T. A. (1999). Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 116, 9-20.
18. Dam, K., Seidler, F. J., and Slotkin, T. A. (2000). Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Dev. Brain Res. 121, 179-187.
19. Dam, K., Seidler, F. J., and Slotkin, T. A. (2003). Transcriptional biomarkers distinguish between vulnerable periods for developmental neurotoxicity of chlorpyrifos: implications for toxicogenomics. Brain Res. Bull. 59, 261-265.
20. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
21. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
22. Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
23. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., and Piomelli, D. (2005). Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3#-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther. 313, 352-358.
24. Fernandez-Ruiz, J., Berrendero, F., Hernandez, M. L., and Ramos, J. A. (2000). The endogenous cannabinoid system and brain development. Trends Neurosci. 23, 14-20.
25. Fernandez-Ruiz, J., Gomez, M., Hernandez, M., de Miguel, R., and Ramos, J. A. (2004). Cannabinoids and gene expression during brain development. Neurotox. Res. 6, 389-401.
26. Garcia-Gil, L., DeMiguel, R.,Munoz, R.M., Cebeira, M., Villanua, M. A., Ramos, J. A., and Fernandez-Ruiz, J. J. (1997). Perinatal D9-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats. Neurotoxicol. Teratol 19, 477-487.
27. Garcia-Gil, L., De Miguel, R., Romero, J., Perez, A., Ramos, J. A., and Fernandez-Ruiz, J. J. (1999). Perinatal delta9-tetrahydrocannabinol exposureaugmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Neurotoxicol. Teratol. 21, 277-283.
28. Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L. V., and Goldberg, S. (2009). Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology 204, 607-616.
29. Harkany, T., Keimpema, E., Barabas, K., and Mulder, J. (2008). Endocannabinoid functions controlling neuronal specification during brain development. Mol. Cell. Endocrinol. 286, S84-S90.
30. Harte, L. C., and Dow-Edwards, D. (2010). Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat. Neurotoxicol. Teratol. 32, 515-524.
31. Hernandez, M., Berrendero, F., Suarez, I., Garcia-Gil, L., Cebeira, M., Mackie, K., Ramos, J. A., and Fernandez-Ruiz, J. (2000). Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Res. 857, 56-65.
32. Huynh, H., and Feldt, L. S. (1970). Conditions under which mean square ratios in repeated measurement designs have exact F-distributions. J. Am. Statist. Assoc. 65, 1582-1589.
33. Johnson, F. O., Chambers, J. E., and Carr, R. L. (2006). Effects of repeated postnatal exposure to chlorpyrifos or methyl parathion in the elevated plusmaze model of anxiety. Toxicologist 90, 1445.
34. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76-81.
35. Kidd, D., Liu, Y., and Cravatt, B. F. (2001). Profiling serine hydrolase activities in complex proteomes. Biochemistry 40, 4005-4015.
36. Koch, D., Lu, C., Fisker-Andersen, J., Jolley, L., and Fenske, R. A. (2002). Temporal association of children's pesticide exposure and agricultural spraying: report of a longitudinal biological monitoring study. Environ. Health Perspect. 110, 829-833.
37. Kumar, A. M., Haney, M., Becker, T., Thompson, M. L., Kream, R. M., and Miczek, K. (1990). Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525, 78-83.
38. Levin, E. D., Addy, N., Baruah, A., Elias, A., Christopher, N. C., Seidler, F. J., and Slotkin, T. A. (2002). Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol. Teratol. 24, 733-741.
39. Liston, C., Watts, R., Tottenham, N., Davidson, M. C., Niogi, S., Ulug, A. M., and Casey, B. J. (2006). Frontostriatal microstructure modulates efficient recruitment of cognitive control. Cereb. Cortex 16, 553-560.
40. Littell, R. C., Milliken, G. A., Stroup, W. W., and Wolfinger, R. D. (1996). In SAS System for Mixed Models. SAS Institute, Cary, NC.
41. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
42. Marco, E. M., Rubino, T., Adriani, W., Viveros, M. P., Parolaro, D., and Laviola, G. (2009). Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. Brain Res. 1257, 25-31.
43. Matias, I., and Di Marzo, V. (2007). Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab. 18, 27-37.
44. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
45. Meyer, A., Seidler, F. J., Aldridge, J. E., and Slotkin, T. A. (2005). Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide chlorpyrifos. Toxicol. Appl. Pharmacol. 203, 154-166.
46. Meyer, A., Seidler, F. J., Aldridge, J. E., Tate, C. A., Cousins, M. M., and Slotkin, T. A. (2004a). Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure. Environ. Health Perspect. 112, 295-301.
47. Meyer, A., Seidler, F. J., and Slotkin, T. A. (2004b). Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ. Health Perspect. 112, 170-178.
48. Molina-Holgado, F., Alvarez, F. J., Gonzalez, I., Antonio, M. T., and Leret, M. L. (1997). Maternal exposure to D9-tetrahydrocannabinol (D9-THC) alters indolamine levels and turnover in adult male and female rat brains regions. Brain Res. Bull. 43, 173-178.
49. Molina-Holgado, F., Amaro, A., Gonzalez, M. I., Alvarez, F. J., and Leret, M. L. (1996). Effect of maternal D9-tetrahydrocannabinol on developing serotonergic neurons. Eur. J. Pharmacol. 316, 39-42.
50. Moore, N. L., Greenleaf, A. L., Acheson, S. K., Wilson, W. A., Swartzwelder, H. S., and Kuhn, C. M. (2010). Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats. J. Pharmacol. Exp. Ther. 335, 294-301.
51. Moreira, F. A., Kaiser, N., Monory, K., and Lutz, B. (2008). Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141-150.
52. Moreira, F. A., and Lutz, B. (2008). The endo annabinoid system: emotion, learning and addiction. Addict. Biol. 13, 196-212.
53. Nagy, Z., Westerberg, H., and Klingberg, T. (2004). Maturation of white matter is associated with the development of cognitive functions during childhood. J. Cogn. Neurosci. 16, 1227-1233.
54. Nomura, D. K., Blankman, J. L., Simon, G. M., Fujioka, K., Issa, R. S., Ward, A. M., Cravatt, B. F., and Casida, J. E. (2008). Activation of the endocannabinoid system by organophosphorus nerve agents. Nat. Chem. Biol. 4, 373-378.
55. Nomura, D. K., and Casida, J. E. (2011). Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain. J. Agric. Food Chem. 59, 2808-2815.
56. Nomura, D. K., Leung, D., Chiang, K. P., Quistad, G. B., Cravatt, B. F., and Casida, J. E. (2005). A brain detoxifying enzyme for organophosphorus nerve poisons. Proc. Natl. Acad. Sci. U.S.A. 102, 6195-6200.
57. Quistad, G. B., Klintenberg, R., Caboni, P., Liang, S. N., and Casida, J. E. (2006). Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol. Appl. Pharmacol. 211, 78-83.
58. Quistad, G. B., Sparks, S. E., and Casida, J. E. (2001). Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. Toxicol. Appl. Pharmacol. 173, 48-55.
59. Quistad, G. B., Sparks, S. E., Segall, Y., Nom ura, D. K., and Casida, J. E. (2002). Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications. Toxicol. Appl. Pharmacol. 179, 57-63.
60. Raines, K. W., Seidler, F. J., and Slotkin, T. A. (2001). Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Dev. Brain Res. 130, 65-72.
61. Rauh, V. A., Garfinkel, R., Perera, F. P., Andrews, H. F., Hoepner, L., Barr, D. B., Whitehead, R., Tang, D., and Whyatt, R. W. (2006). Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118, e1845-e1859.
62. Richardson, J. R., and Chambers, J. E. (2005). Effects of repeated oral postnatal exposure to chlorpyrifos on cholinergic neurochemistry in developing rats. Toxicol. Sci. 84, 352-359.
63. Ruckart, P. Z., Kakolewski, K., Bove, F. J., and Kaye, W. E. (2004). Long-term neurobehavioral health effects of methyl parathion exposure in children in Mississippi and Ohio. Environ. Health Perspect. 112, 46-51.
64. Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 13, 1113-1119.
65. Schneider, M. (2009). Cannabis use in pregnancy and early life and its consequences: animal models. Eur. Arch. Psychiatry Clin. Neurosci. 259, 383-393.
66. Schneider, M., Drews, E., and Koch, M. (2005). Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55, 212-2. Behav. Pharmacol. 16, 447-454.
67. Slotkin, T. A., Cousins, M. M., Tate, C. A., and Seidler, F. J. (2001). Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res. 902, 229-243.
68. Slotkin, T. A., Seidler, F. J., and Fumagalli, F. (2007). Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily. Environ. Health Perspect. 115, 909-916.
69. Slotkin, T. A., Tate, C. A., Cousins, M. M., and Seidler, F. J. (2002). Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Dev. Brain Res. 133, 163-173.
70. Slotkin, T. A., Tate, C. A., Ryde, I. T., Levin, E. D., and Seidler, F. J. (2006). Organophosphate insecticides target the serotonergic system in developing rat brain regions: disparate effects of diazinon and parathion at doses spanning the threshold for cholinesterase inhibition. Environ. Health Perspect. 114, 1542-1546.
71. Slotkin, T. A., and Seidler, F. J. (2007). Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats. Brain Res. Bull. 73, 301-309.
72. Stella, N., Schweitzer, P., and Piomelli, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
73. Suarez, I., Bodega, G., Fernandez-Ruiz, J., Ramos, J. A., Rubio, M., and Fernandez, B. (2004). Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal D9-tetrahydrocannabinol exposure. Cerebellum 3, 66-74.
74. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
75. Taber, K. H., and Hurley, R. A. (2009). Endocannabinoids: stress, anxiety, and fear. J. Neuropsychiatry Clin. Neurosci. 21, 109-113.
76. Timchalk, C., Poet, T. S., and Kousba, A. A. (2006). Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos. Toxicology 220, 13-25.
77. Timofeeva, O. A., Roegge, C. S., Seidler, F. J., Slotkin, T. A., and Levin, E. D. (2008a). Persistent cognitive alterations in rats after early postnatal exposure to low doses of the organophosphate pesticide, diazinon. Neurotoxicol. Teratol. 30, 38-45.
78. Timofeeva, O. A., Sanders, D., Seemann, K., Yang, L., Hermanson, D., Regenbogen, S., Agoos, S., Kallepalli, A., Rastogi, A., Braddy, D., et al. (2008b). Persistent behavioral alterations in rats neonatally exposed to low doses of the organophosphate pesticide, parathion. Brain Res. Bull. 77, 404-411.
79. Vela, G., Martin, S., Garcia-Gil, L., Crespo, J. A., Ruiz-Gayo, M., Fernandez-Ruiz, J. J., Garcia-Lecumberri, C., Pelaprat, D., Fuentes, J. A., Ramos, J. A., et al. (1998). Maternal exposure to D9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res. 807, 101-109.
80. Wang, X., Dow-Edwards, D., Anderson, V., Minkoff, H., and Hurd, Y. L. (2006). Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J. 6, 255-264.
81. Whyatt, R. M., Rauh, V., Barr, D. B., Camann, D. E., Andrews, H. F., Garfinkel, R., Hoepner, L. A., Diaz, D., Dietrich, J., Reyes, A., et al. (2004). Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ. Health Perspect. 112, 1125-1132.
82. Xie, S., Borazjani, A., Hatfield, M. J., Edwards, C. C., Potter, P. M., and Ross, M. K. (2010). Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. Chem. Res. Toxicol. 23, 1890-1904.
83. Zheng, Q., Olivier, K., Won, Y. K., and Pope, C. N. (2000). Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. Toxicol. Sci. 55, 124-132.